Beyond lipid metabolism, fetuin-A has been implicated in promoting insulin resistance by inhibiting insulin receptor tyrosine kinase activity, and in amplifying systemic inflammation through activation of Toll-like receptor 4 pathways. The gene discussed is TLR4; the disease is Insulin resistance.